Physician profile
Rose Ingram
NPI 1982146601
$776.25
in general payments reported to CMS, 2019-2025
9 companies · $230 in 2025
The $230 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $211 · 2022: $54.58 · 2023: $239 · 2024: $42.07 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $280.93 | 2023-2025 | Jetstream Sc, Therasphere Administration Set, General - Atherectomy |
| Bard Peripheral Vascular, INC. | $127.30 | 2021-2022 | |
| Depuy Synthes Sales INC. | $97.27 | 2021-2022 | |
| Abbvie INC. | $88.48 | 2023-2024 | |
| Merz North America, INC. | $75.09 | 2023 | Xeomin |
| Medtronic, INC. | $40.71 | 2021 | |
| Shockwave Medical, INC | $26.03 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $23.37 | 2024 | (5154) Azurion 7 M20 Gc |
| Galderma Laboratories, L.P. | $17.07 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rose Ingram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.